ThetaPal ThetaPal

Manufacturing / Pharmaceutical Preparations

Vera Therapeutics, Inc.

VERA

$29.91

+$0.21 (+0.70%)

Price as of Oct 9, 2026 18:53 UTC

2.4 B

Market Cap (Mid Cap)

17%

IV Rank

67.9%

Implied Volatility

Nov 03

Next Earnings

Technical Signals as of Oct 7
Bearish
0 of 7

Trend

  • Above 20-day average $32.17
  • Above 50-day average $33.40
  • Above 200-day average $36.09 · -16.2%
  • Moving averages stacked Not aligned

Momentum

  • Golden cross (50/200) Down · 55d ago
  • Momentum cross (20/50) Down · 50d ago

Volume

  • Below-average volume 1.3x avg

Price & Trend

Daily candles with EMA 20, SMA 50. Drag to zoom.

Options Activity & Greeks

Implied volatility, flow, and dealer positioning from the options market.

Put/Call Ratio

11.23

Bearish skew

Implied Volatility

67.9%

0% percentile

IV vs Realized

Options rich

30d HV 55.5%

Options Heat Map

Delta-risk grid for VERA options across strikes and expirations. Hover any cell for full Greeks.

Loading option chain data...

Insider Trades

5 buys 33 sells
Date Insider Title Type Shares Value Since Trade
Sep 15, 2026 Fordyce Marshall Exercise 18,500 $53,591 +926.3%
Sep 15, 2026 Fordyce Marshall Exercise 18,500 $0 -11.7%
Sep 15, 2026 Fordyce Marshall Sell 18,500 $684,500 -19.6%
Sep 11, 2026 Young Joseph R Exercise 5,000 $19,698 +654.6%
Sep 11, 2026 Young Joseph R Exercise 5,000 $0 -15.2%
Sep 02, 2026 Fordyce Marshall Exercise 18,500 $0 -16.6%
Sep 02, 2026 Fordyce Marshall Sell 18,500 $649,642 -15.3%
Sep 02, 2026 Fordyce Marshall Exercise 18,500 $53,591 +926.3%
Aug 03, 2026 Boman Nancy Lee Grant 63,011 $0 -7.8%
Aug 03, 2026 Boman Nancy Lee Grant 44,987 $0 -7.8%

Earnings History

Date Quarter EPS Est. EPS Actual Surprise Result
Aug 03, 2026 Q2 2026 -$1.61
Mar 31, 2026 Q1 2026 -$1.35 -$1.69 -24.9% Miss
Dec 31, 2025 Q4 2025 -$1.31 -$1.39 -6.3% Miss
Sep 30, 2025 Q3 2025 -$1.16 -$1.26 -8.8% Miss
Jun 30, 2025 Q2 2025 -$0.84 -$1.20 -43.2% Miss
Mar 31, 2025 Q1 2025 -$0.75 -$0.81 -8.0% Miss

Track VERA with ThetaPal

Get insider trade alerts, AI portfolio analysis, and options roll recommendations for VERA and your entire portfolio.